ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Proteinuria"

  • 2022 American Transplant Congress

    Dietary Sodium Intake And Blood Pressure In Living Kidney Donors (SPLID): Rationale And Design Of A Pilot Single-center Crossover Single-blind Randomized Controlled Trial

    E. Tantisattamo1, U. G. Reddy1, A. J. Ferrey1, H. Ichii2, D. C. Dafoe2, H. Moradi1, C. M. Rhee1, K. Kalantar-Zadeh1

    1Division of Nephrology, Hypertension and Kidney Transplantation, Department of Medicine, University of California Irvine School of Medicine, Orange, CA, 2Division of Kidney and Pancreas Transplantation, Department of Surgery, University of California Irvine School of Medicine, Orange, CA

    *Purpose: Since living kidney donors(LKD) are generally healthy and non-hypertensive individuals, non-pharmacologic interventions are likely to be an acceptable and practical approach to preventing hypertension(HTN).…
  • 2022 American Transplant Congress

    Intermediate Term Outcomes of SGLT2 Inhibitors Amongst Diabetic Kidney Transplant Recipients

    C. Song1, A. Brown2, R. Winstead1, S. Sterling1, I. Yakubu2, J. Christensen2, G. Gupta2

    1Pharmacy, VCUHS, Richmond, VA, 2VCUHS, Richmond, VA

    *Purpose: The use of Sodium Glucose Linked Transporter Inhibitors (SGLT-2i) among non-transplant diabetic patients with chronic kidney disease (CKD) has demonstrated reduced cardiovascular mortality, delayed…
  • 2022 American Transplant Congress

    Clinical Evolution of Patients with De Novo DSA After Kidney Transplantation

    C. López del Moral1, N. Lachmann2, S. Hergovits2, D. Stauch2, A. Akifova3, M. Naik3, B. Osmanodja3, D. Schmidt3, K. Budde3

    1Nephrology department-IDIVAL, Hospital Universitario Marqués de Valdecilla, Santander, Spain, 2Institute for Transfusion Medicine, HLA-Laboratory, Charité - Universitätsmedizin, Berlin, Germany, 3Department of Nephrology and Medical Intensive Care, Charité - Universitätsmedizin, Berlin, Germany

    *Purpose: De novo donor-specific antibodies(dnDSA) are related to antibody-mediated rejection(ABMR), but the evolution of patients after dnDSA is variable and not always ABMR and graft…
  • 2022 American Transplant Congress

    Association of Change in Kidney Volume with Proteinuria After Donation

    M. Tsujita1, K. Uchida1, K. Morozumi1, K. Futamura2, T. Hiramitsu2, M. Okada2, S. Narumi2, N. Goto2, Y. Watarai2

    1Masuko Memorial Hospital, Nagoya, Japan, 2Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital, Nagoya, Japan

    *Purpose: In living kidney transplantation, the risk of end-stage kidney disease in kidney donors is crucial, however, it still remains to be resolved. Any useful…
  • 2022 American Transplant Congress

    Utilisation and Clinical Outcomes of Kidney Transplants from Deceased Donors with Albuminuria in the UK: A Cohort Study

    G. Greenhall1, M. Robb1, R. Johnson1, M. Ibrahim1, R. Hilton2, L. Tomlinson3, C. J. Callaghan2, C. Watson4

    1NHS Blood and Transplant, Bristol, United Kingdom, 2Guy's Hospital, London, United Kingdom, 3London School of Hygiene and Tropical Medicine, London, United Kingdom, 4University of Cambridge, Cambridge, United Kingdom

    *Purpose: Urinalysis is a standard component of the assessment of potential deceased kidney donors in the UK. The value of albuminuria as a biomarker for…
  • 2022 American Transplant Congress

    Belatacept Conversion in Proteinuric Kidney Transplant Recipients: Effects in a Prospective Trial and a Retrospective Cohort

    O. Efe1, A. Al Jurdi1, D. Wojciechowski2, K. Safa1, H. Gilligan1, A. Chandraker3, J. Azzi3, A. Weins3, L. V. Riella1

    1Center for Transplantation Sciences, Massachusetts General Hospital, Charlestown, MA, 2UT Southwestern Medical Center, Dallas, TX, 3Brigham and Women's Hospital, Boston, MA

    *Purpose: Proteinuria after kidney transplantation is associated with worse allograft outcomes. B7-1 expression by podocytes has been linked to proteinuria by inducing podocyte migration which…
  • 2022 American Transplant Congress

    Plasmapheresis and Rituximab for Prevention of Focal Segmental Glomerulosclerosis Recurrence Post-Kidney Transplantation

    A. N. Yun1, A. W. Rogers1, J. C. Krisl1, A. Kagan2, H. E. Adrogue2, A. J. Khan2, P. Khairallah2, S. G. Yi3, M. J. Hobeika3, R. R. McMillan3, H. Podder3, A. O. Gaber3, R. J. Knight3

    1Pharmacy, Houston Methodist Hospital, Houston, TX, 2Nephrology, Houston Methodist Hospital, Houston, TX, 3Surgery, Houston Methodist Hospital, Houston, TX

    *Purpose: Primary focal segmental glomerulosclerosis (FSGS) recurs after kidney transplantation (KT) in 30-50% of recipients with a median time of 1.5 months post-KT. Recurrence is…
  • 2022 American Transplant Congress

    Proteome Profiling of Recurrent Primary Focal Segmental Glomerulosclerosis (FSGS) Plasma Samples Reveals Potential Proteins Involved in Primary FSGS

    L. Gallon1, N. Ahsan2, V. Mas3, J. Leventhal1, L. Fornelli2

    1Northwestern Univ NMFF, Chicago, IL, 2Mass Spectrometry, Proteomics and Metabolomics Core Facility, Department of Chemistry and Biochemistry, The University of Oklahoma, Oklahoma, OK, 3University of Maryland, Baltimore, MD

    *Purpose: The presumed etiology of primary FSGS is a plasma factor that results in general podocyte dysfunction with partial and/or unpredictable response to immunosuppressive therapy…
  • 2022 American Transplant Congress

    Impact of Varying Levels of Normal Range Baseline Donor Derived Cell Free DNA on Medium-Term Outcomes Following Kidney Transplantation

    K. K. Sureshkumar1, A. Grazier2, B. Chopra1

    1Nephrology, Medicine Institute, Allegheny General Hospital, Pittsburgh, PA, 2Abdominal Transplantation, Allegheny General Hospital, Pittsburgh, PA

    *Purpose: Donor derived cell free DNA (dd-cfDNA) is a biomarker with high negative predictive value for ruling out acute rejection (AR) in kidney allografts. Baseline…
  • 2022 American Transplant Congress

    Adverse Renal Events After BNT162b2 Pfizer/BioNTech COVID-19 Vaccine in Kidney Transplant Recipients

    H. K. Sran1, E. Wong1, M. R. D'Costa2, A. Lim2, Q. Lim2, A. Vathsala1

    1National University of Singapore, Singapore, Singapore, 2National University Centre for Organ Transplantation, National University Hospital, Singapore, Singapore

    *Purpose: Adverse events of a novel mRNA vaccine are not well described in Kidney Transplant Recipients(KTR), especially the risk of immune activation or recurrent glomerulonephritis(GN),…
  • 1
  • 2
  • 3
  • …
  • 8
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences